Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993215priorityCriticalpatent/ECSP993215A/en
Publication of ECSP993215ApublicationCriticalpatent/ECSP993215A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Una composición farmacéutica, cuya composición comprende: Un sensibilizador de insulina y otro agente antidiabético y un vehículo farmacéuticamente aceptable para el mismo, donde la composición está otro agente antidiabético, y el uso de tal composición en medicina.A pharmaceutical composition, the composition of which comprises: An insulin sensitizer and another antidiabetic agent and a pharmaceutically acceptable vehicle therefor, where the composition is another antidiabetic agent, and the use of such composition in medicine.
ECSP9932151999-11-111999-11-11
NEW COMPOSITION AND USE
ECSP993215A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH SENSITIZER AND SUCH AGENT.
USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE.
Pharmaceutical composition comprising: i) an at1 receptor antagonist or a salt, ii) an insulin sensitizer or a salt and iii) a pharmaceutically acceptable carrier; use for the prevention, delay of progress or treatment of hypertension, diabetes, among others (div. sol. 2034-01).
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
USE OF AN INSULIN SENSITIZER AND AN ANTIHIPERGLUCEMIC AGENT FOR THE PREPARATION OF A PHARMACEUTICAL MEDICINAL AND COMPOSITION THAT UNDERSTANDS SENSITIZER AND SUCH AGENT